Pharmaceuticals Blog
Roche ordered to pay $10.6 million in Accutane trial
April 28th, 2008 by Todd HagemanA New Jersey jury awarded $10.6 million to a woman who claimed the acne drug Accutane caused her inflammatory bowel disease.
Last week, Pharmalot and the Wall Street Journal reported that a nine-member, state-court jury concluded that Accutane’s maker, Hoffman-LaRoche Inc., failed to warn the woman that the drug can cause IBD.
Kamie Kendall, 24, began taking the drug when she was 12. She was diagnosed with ulcerative colitis at 14. In 2006, her colon was removed. The jury awarded $10.5 million of compensatory damages and $78,500 for medical expenses.
This is the second case to go to trial in New Jersey. Last June, a jury in the same court awarded $2.6 million in another IBD case. Last fall, a Florida jury awarded $7 million to a 31-year-old welder who took Accutane for nine years and developed Crohn’s disease.
If you or someone you know has been hurt as a result of taking a dangerous medication, contact Todd Hageman toll free at 1-877-767-3108.
